Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Imnovid (pomalidomide) - Important Safety Information from Celgene Ltd. as approved by the Health Products Regulatory Authority
Notice type:
3rd Party Publications
Date:
30/04/2015
Problem Or Issue:
Important safety information communication from Celgene Ltd. to minimise the risk of serious hepatotoxicity, interstitial lung disease and cardiac failure associated with Imnovid (pomalidomide).
Important Safety Information - Imnovid (pomalidomide)
« Back
Date Printed: 26/04/2024